PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Recombinant Human VEGF-165 (Animal-Free), 10 μg
Recombinant Human VEGF-165 (carrier-free), 10 μg
Recombinant Human VEGF-165 (carrier-free), 100 μg
Recombinant Human VEGF-165 (carrier-free), 25 μg
Recombinant Human VEGF-165 (carrier-free), 500 μg
Recombinant Human VEGF-C (carrier-free), 10 μg
Recombinant Human VEGF-C (carrier-free), 100 μg
Recombinant Human VEGF-C (carrier-free), 25 μg
Recombinant Human VEGF-D (carrier-free), 10 µg
Recombinant Human VEGF-D (carrier-free), 2 µg
Recombinant Human VEGFR1 (carrier-free), 10 μg
Recombinant Human VEGFR1 (carrier-free), 25 μg
Recombinant Human VEGFR2-Fc Chimera (carrier-free), 10 μg
Recombinant Human VEGFR2-Fc Chimera (carrier-free), 100 μg
Recombinant Human VEGFR2-Fc Chimera (carrier-free), 25 μg
Recombinant Human Vitronectin (carrier-free), 100 μg